RSS

neurological disorders

Data on the involvement of the histaminergic system in the stimulating effect of a new drug candidate (THN 102) are being presented at the 11th Federation of European Neuroscience Societies (FENS) Forum by biopharma company, Theranexus. more

News

A clinical study, performed by researchers from the UK and China, has demonstrated that novel triple receptor agonists (TAs) originally developed to treat Type 2 diabetes, significantly reversed memory loss in a mouse model of Alzheimer’s disease. more

News